EPISODE · Jun 13, 2023 · 8 MIN
FDA considering a second Alzheimer's drug
from POLITICO's Pulse Check · host POLITICO
Outside advisers to the FDA recommended that the agency grant traditional approval to the Alzheimer’s drug Leqembi. Host Ben Leonard talks with Katherine Ellen Foley about what final approval could mean for patients. Learn more about your ad choices. Visit megaphone.fm/adchoices
Embed this episode
NOW PLAYING
FDA considering a second Alzheimer's drug
0:00
8:26
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of POLITICO's Pulse Check?
This episode is 8 minutes long.
When was this POLITICO's Pulse Check episode published?
This episode was published on June 13, 2023.
Can I download this POLITICO's Pulse Check episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!